Physiologically based toxicokinetic models and their application in human exposure and internal dose assessment
Human populations may exhibit large interindividual variation in toxicokinetic response to chemical exposures. Rapid developments in dosimetry research have brought medicine and public health closer to understanding the biological basis of this heterogeneity. The toxicokinetic behavior of chemicals is, in part, controlled by the properties of the epithelium surrounding organs, some of which are effective barriers to penetration into the systemic circulation. Physiologically based toxicokinetic (PBTK) models have been developed and used to simulate the mechanism of uptake into the systemic circulation, to extrapolate between doses and exposure routes, and to estimate internal dosimetry and sources of heterogeneity in animals and humans. Recent improvements to PBTK models include descriptions of active transport across biological membranes, carrier-mediated clearance, and fractal kinetics. The expanding area of toxicogenetics has provided valuable insight for delineating toxicokinetic differences between individuals; genetic differences include inherited single nucleotide polymorphisms, copy number variants, and dynamic changes in the methylation pattern of imprinted genes. This chapter discusses the structure of PBTK models and how toxicogenetic information and newer biological descriptions have improved our understanding of variability in response to toxicant exposures.
KeywordsExposure Assessment Fractal Kinetic Mixed Venous Blood Toxicant Exposure Intestinal Membrane
Unable to display preview. Download preview PDF.
- 4.Potts RO, Bommannan DB, Guy RH (1992) Percutaneous absorption. In: H Mukhtar (ed.): Pharmacology of the Skin. CRC Press, Boca Raton, 13–28Google Scholar
- 5.Johnson LR (2006) Physiology of the Gastrointestinal Tract. Elsevier Academic Press, BurlingtonGoogle Scholar
- 16.Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmöller J, Johne A, Cascorbi I, Gerloff T, Roots I, Eichelbaum M, Brinkmann U (2000) Functional polymorphisms of the human multidrugresistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 97: 3473–3478PubMedCrossRefGoogle Scholar
- 18.You G, Morris ME (2007) Drug Transporters: Molecular Characterization and Role in Drug Disposition. Wiley-Interscience, HobokenGoogle Scholar
- 22.Bassingthwaighte JB, Liebovitch LS, West BJ (1994) Fractal Physiology. Oxford University Press, New YorkGoogle Scholar
- 39.Yoshimura K, Hanaoka T, Ohnami S, Ohnami S, Kohno T, Liu Y, Yoshida T, Sakamoto H, Tsugane S (2003) Allele frequencies of single nucleotide polymorphisms (SNPs) in 40 candidate genes for gene-environment studies on cancer: Data from population-based Japanese random samples. J Hum Genet 48: 654–658PubMedCrossRefGoogle Scholar
- 43.Elston RC (1995) Linkage and association to genetic markers. Exp Clin Immunogen 12: 129–140Google Scholar
- 49.ACGIH (2007) Documentation of the TLVs® and BEIs®. American Conference of Governmental Industrial Hygienist, CincinnatiGoogle Scholar
- 50.Deutsche Forschungsgemeinschaft, Commission for Investigation of Health Hazards of Chemical Compounds in the Work Area (2007) List of MAK and BAT Values 2006: Maximum Concentrations and Biological Tolerance Values at the Workplace. Wiley-VCH, WeinheimGoogle Scholar